Viewing Study NCT03267433


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-01-06 @ 6:52 AM
Study NCT ID: NCT03267433
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-11-13
First Post: 2017-08-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Rituximab With or Without Stem Cell Transplant in Treating Patients With Minimal Residual Disease-Negative Mantle Cell Lymphoma in First Complete Remission
Sponsor: ECOG-ACRIN Cancer Research Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module